Corvus Pharmaceuticals Inc (CRVS) — Cash Flow Quality Index

Latest as of March 2025: -0.54x

Corvus Pharmaceuticals Inc (CRVS) has a Cash Flow Quality Index of -0.54x as of March 2025. Operating cash flow of $-8.26 Million is below net income of $15.19 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CRVS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.54x

Operating CF / Net Income

Operating Cash Flow

$-8.26 Million

USD

Net Income

$15.19 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Corvus Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Corvus Pharmaceuticals Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.